Kohtaro Abe
About
Kohtaro Abe is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery.
According to data from OpenAlex, Kohtaro Abe has authored 112 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pulmonary and Respiratory Medicine, 59 papers in Cardiology and Cardiovascular Medicine and 16 papers in Surgery. Recurrent topics in Kohtaro Abe's work include Pulmonary Hypertension Research and Treatments (77 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Issues in Pregnancy (12 papers). Kohtaro Abe is often cited by papers focused on Pulmonary Hypertension Research and Treatments (77 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Issues in Pregnancy (12 papers). Kohtaro Abe collaborates with scholars based in Japan, United States and United Kingdom. Kohtaro Abe's co-authors include Norbert F. Voelkel, Harm Jan Bogaard, Anton Vonk Noordegraaf, Hiroaki Shimokawa, Masahiko Oka, Ivan F. McMurtry, Toyokazu Uwatoku, Keiji Oi, Karen A. Fagan and Michie Toba and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.
In The Last Decade
Kohtaro Abe
98 papers receiving 3.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kohtaro Abe Japan | 27 | 2.0k | 1.5k | 746 | 489 | 419 | 112 | 3.4k | ||
| René P. Michel Canada | 23 | 2.1k 1.0× | 947 0.7× | 448 0.6× | 599 1.2× | 796 1.9× | 100 | 3.6k | ||
| Klaus‐Michael Müller Germany | 32 | 1.8k 0.9× | 691 0.5× | 576 0.8× | 899 1.8× | 210 0.5× | 147 | 3.8k | ||
| Seiichiro Sakao Japan | 30 | 2.1k 1.0× | 836 0.6× | 623 0.8× | 268 0.5× | 436 1.0× | 168 | 2.9k | ||
| Caroline Cheng Netherlands | 35 | 710 0.3× | 1.1k 0.8× | 1.3k 1.8× | 1.1k 2.2× | 348 0.8× | 92 | 4.1k | ||
| Dirk Skowasch Germany | 28 | 1.6k 0.8× | 919 0.6× | 289 0.4× | 415 0.8× | 898 2.1× | 215 | 3.0k | ||
| Robert A. Quaife United States | 23 | 1.1k 0.5× | 2.3k 1.6× | 581 0.8× | 628 1.3× | 144 0.3× | 65 | 3.2k | ||
| Glen A. Laine United States | 30 | 878 0.4× | 966 0.7× | 646 0.9× | 1.3k 2.7× | 467 1.1× | 125 | 3.9k | ||
| Rajabrata Sarkar United States | 26 | 649 0.3× | 525 0.4× | 662 0.9× | 797 1.6× | 417 1.0× | 101 | 2.5k | ||
| Kimihiro Komori Japan | 34 | 1.3k 0.6× | 1.2k 0.8× | 1.2k 1.7× | 1.8k 3.7× | 908 2.2× | 237 | 4.4k | ||
| Steve Landas United States | 29 | 1.0k 0.5× | 507 0.3× | 662 0.9× | 727 1.5× | 221 0.5× | 96 | 3.2k |
Countries citing papers authored by Kohtaro Abe
Since
Specialization
Citations
This map shows the geographic impact of Kohtaro Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohtaro Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohtaro Abe more than expected).
Fields of papers citing papers by Kohtaro Abe
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kohtaro Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohtaro Abe. The network helps show where Kohtaro Abe may publish in the future.
Co-authorship network of co-authors of Kohtaro Abe
This figure shows the co-authorship network connecting the top 25 collaborators of Kohtaro Abe. A scholar is included among the top collaborators of Kohtaro Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohtaro Abe. Kohtaro Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Inoue, Shujiro, Kazuo Sakamoto, Masatsugu Nozoe, et al.. (2025). Efficacy of sinus rhythm maintenance after catheter ablation for atrial fibrillation in patients with transthyretin amyloid cardiomyopathy. Heart Rhythm. 22(12). e1221–e1229.
2.
Ikeda, M., Yuzo Yamasaki, Koji Sagiyama, et al.. (2025). Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy. Pulmonary Circulation. 15(4). e70170–e70170.
3.
Hashimoto, Toru, Shouji Matsushima, Takeo Fujino, et al.. (2025). Effects of Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors on Relationship Between B‐Type Natriuretic Peptide and Hemoglobin Levels in Patients With Cardiorenal Anemia Syndrome. Cardiovascular Therapeutics. 2025(1). 3143864–3143864.
4.
Ogo, Takeshi, Toshiro Shinke, Nobutaka Ikeda, et al.. (2025). Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA). Circulation Cardiovascular Interventions. 18(12). e016172–e016172.
5.
Kopeć, Grzegorz, Paul R. Forfia, Kohtaro Abe, et al.. (2024). Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(1). e12330–e12330.
6.
Skoro‐Sajer, Nika, Karen Sheares, Paul R. Forfia, et al.. (2024). Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(2). e12406–e12406.
7.
Tamura, Yuichi, Hiraku Kumamaru, Ichizo Tsujino, et al.. (2024). Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study). Pharmaceuticals. 17(5). 555–555.
8.
Sakamoto, Ichiro, Ayako Ishikita, Hidetaka Kaku, et al.. (2023). Visibility of Pulmonary Valve and Pulmonary Regurgitation on Intracardiac Echocardiography in Adult Patients with Tetralogy of Fallot. Journal of Cardiovascular Development and Disease. 10(1). 24–24.
9.
Kuwana, Masataka, Kohtaro Abe, Hideyuki Kinoshita, et al.. (2023). Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension. Pulmonary Circulation. 13(1). e12198–e12198.
10.
Enzan, Nobuyuki, Shouji Matsushima, Soichiro Ikeda, et al.. (2023). ZBP1 Protects Against mtDNA-Induced Myocardial Inflammation in Failing Hearts. Circulation Research. 132(9). 1110–1126.
11.
Hosokawa, Kazuya, et al.. (2022). Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis. Life. 12(6). 780–780.
12.
Yamasaki, Yuzo, Takeshi Kamitani, Kohtaro Abe, et al.. (2021). Diagnosis of Pulmonary Hypertension Using Dynamic Chest Radiography. American Journal of Respiratory and Critical Care Medicine. 204(11). 1336–1337.
13.
Watanabe, Takanori, Kohtaro Abe, Kazuya Hosokawa, et al.. (2021). Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension. Journal of the American Heart Association. 10(23). e022712–e022712.
14.
Tagashira, Hideaki, Satomi Kita, Tomo Kita, et al.. (2020). Genetic knockout and pharmacologic inhibition of NCX1 attenuate hypoxia-induced pulmonary arterial hypertension. Biochemical and Biophysical Research Communications. 529(3). 793–798.
15.
Kawakami, Takashi, Hiromi Matsubara, Kohtaro Abe, et al.. (2020). Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study. BMJ Open. 10(2). e028831–e028831.
16.
Alzoubi, Abdallah, Michie Toba, Kohtaro Abe, et al.. (2013). Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 304(12). H1708–H1718.
17.
Abe, Kohtaro, Michie Toba, Abdallah Alzoubi, et al.. (2010). Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension. Circulation. 121(25). 2747–2754.
18.
Abe, Kohtaro, et al.. (2004). Rhoキナーゼ長期阻害は内皮性NO合成とは無関係に低酸素誘発肺高血圧を改善する(Long-term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice Independent of Endothelial NO Synthase). Circulation. 68. 468–468.
19.
Abe, Kohtaro, Toyokazu Uwatoku, Yasuharu Matsumoto, et al.. (2003). Long-Term Inhibition of Rho-Kinase Markedly Ameliorates Monocrotaline-lnduced Pulmonary Hypertension in Rats. Japanese Circulation Journal-english Edition. 67. 245.
20.
Uwatoku, Toyokazu, Hiroaki Shimokawa, Kohtaro Abe, Yasuharu Matsumoto, & Akira Takeshita. (2002). Application of nanotechnology for the prevention of neointimal formation after balloon injury in rats. Japanese Circulation Journal-english Edition. 66. 153.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by René P. Michel Breakdown of academic impact, for papers by Klaus‐Michael Müller Breakdown of academic impact, for papers by Seiichiro Sakao Breakdown of academic impact, for papers by Caroline Cheng Breakdown of academic impact, for papers by Dirk Skowasch Breakdown of academic impact, for papers by Robert A. Quaife Breakdown of academic impact, for papers by Glen A. Laine Breakdown of academic impact, for papers by Rajabrata Sarkar Breakdown of academic impact, for papers by Kimihiro Komori Breakdown of academic impact, for papers by Steve Landas